antiplatelet agents
Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of       eicosapentaenoic acid and antiplatelet agents in patients with hypertension and       hyperlipidemia.
Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of       eicosapentaenoic acid and  @SUBJECT$   @PREDICAT$   @OBJECT$  with hypertension and       hyperlipidemia.